1-Deoxynojirimycin

CAS No. 19130-96-2

1-Deoxynojirimycin( Duvoglustat )

Catalog No. M17402 CAS No. 19130-96-2

1-Deoxynojirimycin is a potent α-glucosidase inhibitor, suppressing postprandial blood glucose, thereby possibly preventing diabetes mellitus.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 34 In Stock
5MG 50 In Stock
10MG 65 In Stock
25MG 135 In Stock
50MG 248 In Stock
100MG 321 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    1-Deoxynojirimycin
  • Note
    Research use only, not for human use.
  • Brief Description
    1-Deoxynojirimycin is a potent α-glucosidase inhibitor, suppressing postprandial blood glucose, thereby possibly preventing diabetes mellitus.
  • Description
    1-Deoxynojirimycin is a potent α-glucosidase inhibitor, suppressing postprandial blood glucose, thereby possibly preventing diabetes mellitus.
  • In Vitro
    ——
  • In Vivo
    Animal Model:db/db miceDosage:20, 40, 80 mg/kg Administration:Intravenously; daily for four weeks Result:Significantly reduced body weight, blood glucose and serum insulin levels; Improved glucose tolerance and insulin tolerance.
  • Synonyms
    Duvoglustat
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    β-glycosidase
  • Research Area
    Metabolic Disease
  • Indication
    ——

Chemical Information

  • CAS Number
    19130-96-2
  • Formula Weight
    163.17
  • Molecular Formula
    C6H13NO4
  • Purity
    >98% (HPLC)
  • Solubility
    H2O : ≥ 34 mg/mL; 208.37 mM
  • SMILES
    C1[C@@H]([C@H]([C@@H]([C@H](N1)CO)O)O)O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Jiang P, et al. Sci Rep. 2015 Feb 24;5:8563.
molnova catalog
related products
  • MK-0533

    MK-0533 is a novel PPARγ partial agonist for the prevention of vascular endothelial dysfunction (VED) and VED-related cardiovascular disease.

  • Aleglitazar

    A potent and balanced dual PPARα/γ agonist (EC50= 50/21 nM).

  • GW 9662

    GW9662 is a selective PPAR antagonist for PPARγ with IC50 of 3.3 nM in a cell-free assay.